Assoc. Prof. PharmDr. Josef JAMPÍLEK, Ph.D.

Education and academic qualifications

  • 2009: Associate Professor of Medicinal Chemistry – University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Pharmacy, Czech Republic
  • 2004: PharmDr., Ph.D. – Charles University, Faculty of Pharmacy, Czech Republic (Medicinal Chemistry)
  • 2000: M.Sc. – Charles University, Faculty of Pharmacy, Czech Republic (Pharmacy)

Professional and Management Training

  • 2011: Effective Professional Communication, Leadership – DEVELOR Czech s.r.o., Czech Republic
  • 2011: Creative Thinking Course – IMPRoPACT, s.r.o., Czech Republic
  • 2008: Project Control – EXPERTIS Praha s.r.o., Czech Republic
  • 2008: Negotiation – DEVELOR Czech s.r.o., Czech Republic
  • 2006–2007: Senior Management Training “Z-Leader” – EXPERTIS Praha s.r.o., Czech Republic
  • 2007: GxP Requirements for R&D – G.M.Project s.r.o., Czech Republic
  • 2006: GMP for API Manufacturing – G.M.Project s.r.o., Czech Republic
  • 2005: Quality Control – G.M.Project s.r.o., Czech Republic
  • 2004: Clinical Drug Trial – Clinical Trial Association & ARCOmed s.r.o., Czech Republic

Professional experience

  • 2009–: Associate Professor – Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic
  • 2009–: External lecturer of Qualified Person Training Course, Institute for Postgraduate Medical Education Prague, Czech Republic
  • 2006–2009: Assistant Professor – Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic
  • 2006–2007: External lecturer of the course Technology of Synthetic Drugs, Department of Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy, Charles University, Czech Republic
  • 2004–2011: Different positions: Senior Specialist, Manager-Head of Laboratory, Senior Scientist – R&D Division, Zentiva Prague, Czech Republic
  • 2000–2003: Scientist – Research Centre of Structure and Mechanism of Action of Potential Drugs B5, Faculty of Pharmacy, Charles University, Czech Republic

Teaching activities

  • Master course of pharmacy: lecturer of Molecular Principles of Drug      Design (Guarantor of the Course), Pharmaceutical Analysis in Industry,      Analytical Chemistry, Medicinal Chemistry
  • Supervisor of diploma, rigorous theses and supervisor of Ph.D.      students in Medicinal Chemistry and Safety & Quality of Drugs

Research activities

  • Design, synthesis and structure-activity relationships of heterocyclic compounds as potential antimicrobial drugs and antineoplastics
  • Design, synthesis and structure-activity relationships of potential photosynthesis inhibitors
  • Design, synthesis and structure-activity relationships of potential transdermal enhancers
  • Study of physico-chemical properties of potential drugs and drug polymorphism
  • Study of in vitro bioavailability, nanoparticles and ADME
  • Pharmaceutical analysis and solid-state analytical techniques

Professional stays abroad

  • 2015: Institute of Inorganic Chemistry and Technology, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Poland (visiting professor)
  • 2014: Department of Pharmaceutical and Toxicological Chemistry, Faculty of Pharmacy, South Kazakhstan State Pharmaceutical Academy, Shymkent, Kazakhstan (visiting professor)
  • 2014, 2015: Department of Biochemistry and Neurobiology, Faculty of Materials Science, AGH University of Science and Technology, Krakow, Poland (visiting professor)
  • 2014: Department of Pharmaceutical Chemistry Faculty of Pharmacy, Kazakh National Medical University, Almaty, Kazakhstan (visiting professor)
  • 2009–present: Institute of Chemistry, University of Silesia in Katowice, Poland (visiting professor)
  • 2000: Pharmazeutisch-Chemisches Institut, Ruprecht-Karls-Universität Heidelberg, Germany (research fellowship)

Other academic activities, research projects, grants

  • Member of State examination commission on undergraduate level, Pharmacy Programme, University of Veterinary Medicine and Pharmacy in Košice, Slovakia (since 2015)
  • Member of State examination commission on doctoral level: Drugs & Biomaterials, Faculty of Chemical Technology, Institute of Chemical Technology in Prague, Czech Republic (2013)
  • Coordinator of Paul Ehrlich MedChem Euro-Ph.D. Network at the Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic (since 2013)
  • Member of organizing committee of conferences Drug Synthesis and Analysis (2008, 2011), Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic
  • Member of doctoral study boards: Medicinal Chemistry and Safety & Quality of Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno
  • Member of State examination commissions on undergraduate or doctoral level, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno

Selected grants

  • 2015: Innovative Composite Biomaterials Contained Bioactive Calcium Phosphates (LIDER/037/481/L-5/13/NCBR). The National Centre for Research and Development in Poland, member of research group
  • 2015: Anti-Invasive Activity of Novel Antimicrobial Chemotherapeutics (IGA VFU Brno 304/2015/FaF). Internal Grant Agency of the University of Veterinary and Pharmaceutical Sciences Brno, principal investigator
  • 2015: Evaluation of Alaptide Derivatives as Potential Modifiers of Transdermal Penetration (IGA VFU Brno 302/2015/FaF). Internal Grant Agency of the University of Veterinary and Pharmaceutical Sciences Brno, member of research group
  • 2014–2017: Matrix Systems for Healing of Skin Defects for Human and Veterinary Use (TAČR TA04010065). Technology Agency of the Czech Republic, member of research group
  • 2014: Study of Antimicrobial Properties of Newly Synthesized Prospective Chemotherapeutics (IGA VFU Brno 52/2014/FaF). Internal Grant Agency of the University of Veterinary and Pharmaceutical Sciences Brno, member of research group
  • 2014: Synthesis of Carboxamides of Kynurenic Acid as Biologically Active Compounds (IGA VFU Brno, 37/2014/FaF). Internal Grant Agency of the University of Veterinary and Pharmaceutical Sciences Brno, principal investigator
  • 2014: Improving Qualification of Students of Ph.D. Educational Programs & Postdoctorates of Agricultural and Veterinary Branches through Engagement in Multidisciplinary Interuniversity Teams (MSM Project No. C3/2014). Centralized Development Project of the Ministry of Education of the Czech Republic in 2014. Member of research group
  • 2012: Synthesis of Hydroxynaphthyl Carboxamides as Biologically Active Compounds (IGA VFU Brno 96/2012/FaF). Internal Grant Agency of the University of Veterinary and Pharmaceutical Sciences Brno, member of research group
  • 2011–2014: Nanotechnology Approaches for Drug Delivery Across Blood-Tissue Barriers (GAČR P304/11/2246). Czech Science Foundation of the Czech Republic, principal investigator
  • 2003: Chalcones and Their Analogues as Potencial Drugs (FRVŠ 2970/G3/2003). University Development Fund of the Ministry of Education of the Czech Republic, co-investigator
  • 2003: Continuation of Potential Antituberculotics and Antimycotics Preparation (FRVŠ 2998/G6/2003). University Development Fund of the Ministry of Education of the Czech Republic, principal investigator
  • 2002: Completion of Potential Antituberculotics and Antimycotics Series Synthesis (FRVŠ 2245/G4/2002). University Development Fund of the Ministry of Education of the Czech Republic, principal investigator
  • 2000–2004: Research Centre for Structure and Mechanism of Action of Potential Drugs (LN00B125). Ministry of Education of the Czech Republic, member of research group
  • 1999–2004: Development, Preparation and Drug Technology (MSM 111600001). Research Aims of the Ministry of Education of the Czech Republic, member of research group
  • 1998–2000: Biologically active derivatives of pyrazine and pyridine (GAUK 026/1998/B-CH/FaF). Grant Agency of the Charles University, member of research group

Non-university activities

  • Member of the panel “Inanimate Nature” of the Expert Board of the Czech Science Foundation (2015–2017)
  • Ad hoc grant reviewer in the branch of Medicinal Chemistry and Pharmacology: National Centre for Research and Development in Poland (2015), Scientific Grant Agency of the Ministry of Education of the Slovak Republic & the Slovak Academy of Sciences (2015), Fulbright Visiting Scholar Program (2014, 2015), Hungarian Scientific Research Fund (2014, 2015), Slovak Research and Development Agency (2012, 2015), Internal Grant Agency of the Ministry of Health of the Czech Republic (2011–2013), South African Medical Research Council (2010–2011), Technology Agency of the Czech Republic (2010–2013)
  • Member of the scientific and/or organizing committees of conferences, for example, World Conference on Physico-Chemical Methods in Drug Discovery and Development, Croatia (2015), Nanomaterials and Nanotechnology Meeting, Czech Republic (2015), Central European Conference "Chemistry towards Biology", Poland (2014), International Symposium and Workshop on Environment and Health, Czech Republic (2012, 2013), Chromatographic Methods of Investigating the Organic Compounds, Poland (since 2012), Drug Synthesis and Analysis, Czech Republic (2008, 2011, 2015)
  • Member of the Editorial Boards of Medicinal Chemistry (since 2015), ChemistrySelect (since 2015), Open Pharmaceutical Sciences Journal (since 2015), ADMET & DMPK (since 2014), Journal of Bioequivalence & Bioavailability (since 2013),Military Medical Science Letters (since 2011)
  • Guest Editor of Current Organic Chemistry (2015–2016), BioMed Research International (2014–2015), ADMET & DMPK (2014), Current Pharmaceutical Design (2010–2011)
  • Ad hoc reviewer, for example, Acta Chromatographica,Anti-Cancer Agents in Medicinal Chemistry, Arabian Journal of Chemistry, ASC Combinatorial Science, Bioorganic & Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Central European Journal of Chemistry,Chemical Biology & Drug Design, Chemical Engineering Journal, ChemMedChem, Combinatorial Chemistry & High Throughput Screening, Current Pharmaceutical Design, Current Organic Synthesis, European Journal of Medicinal Chemistry, European Journal of Organic Chemistry, Expert Opinion on Drug Discovery, Frontiers in Life Science, International Journal of Medicinal Chemistry, Journal of Applied Biomedicine, Journal of Biochemical & Molecular Toxicology, Journal of Biomolecular Structure & Dynamics, Journal of Combinatorial Chemistry, Journal of Molecular Structure, Journal of Nanoscience and Nanotechnology, Letters in Drug Design & Discovery, Letters in Organic Chemistry, Medicinal Chemistry, Molecules, Monatshefte für Chemie, Pest Management Science, Pharmaceutical Research, Steroids, Tuberculosis
  • Member of Working Group on New TB Drugs (since 2015), International Association of Physical Chemists (since 2014), Czech Pharmaceutical Society – Synthetic Drugs Section (since 2002) and Czech Chemical Society – Organic and Bioorganic Section (since 2002)

Most significant professional accomplishments

  • Invited/plenary lectures on international medicinal chemistry or pharmaceutical analysis conferences, for example, 13th Annual Congress of International Drug Discovery Science & Technology, China (2015), 5th Annual Symposium of Drug Delivery System, China (2015), 24th Central European Conference ECOpole’15, Poland (2015), 4th World Conference on Physico-Chemical Methods in Drug Discovery and Development, Croatia (2015), Pharma Europe-2015, Spain (2015), 9th Joint Meeting in Medicinal Chemistry, Greece (2015), 4th Nanomaterials and Nanotechnology Meeting, Czech Republic (2015), 13th Ibn Sina International Conference on Pure and Applied Heterocyclic Chemistry, Egypt (2015), Pharmaceutical Education, Scientific and Manufacturing as a Reference to the Strategy Kazakhstan-2020, Kazakhstan (2014), 6th Conversatory on Medicinal Chemistry, Poland (2014), 7th Central European Conference "Chemistry towards Biology", Poland (2014), BIT′s Annual International Congress of Medichem, China (2013, 2014), International Symposium and Workshop on Environment and Health, Czech Republic (2012, 2013), Chromatographic Methods of Investigating the Organic Compounds, Poland (since 2012), EU Assessors Training on Efficient and Effective Quality Assessment, Czech Republic (2012)
  • Awards, for example, "Prix de Pharmacie 2004" of Aventis, "Outstanding Reviewer 2014–2015 Award" awarded by Wiley-VCH and, as a member of teams, "Most Cited Paper 2006–2009 Award" granted by the journal Bioorganic & Medicinal Chemistry, Elsevier and "2011 Industrial Affairs Innovation Award" granted by Sanofi

Selected Peer-reviewed publications

2016

  • Jampílek, J. Potential of      agricultural fungicides for antifungal drug discovery. Exp. Opin. Drug Dis.. 2016, 11 (1), 1-9.

2015

  • Cieslik, W., Spaczyńska, E.; Malarz, K.; Tabak, D.; Nevin, E.; O´Mahony, J.; Coffey, A.; Mrozek-Wilczkiewicz, A.; Jampílek, J.; Musioł, R. Investigation of the Antimycobacterial Activity of 8-Hydroxyquinoline. Med. Chem. 2015, 11 (8), 771-779.
  • Jampílek, J.; Kráľová, K. Application of Nanotechnology in Agriculture and Food Industry, Its Prospects and Risks. Ecol. Chem. Eng. S. 2015, 22 (3), 321-361.
  • Ulahannan, R.T.; Panicker, Y.C.; Varghese, H.T.; Musioł, R.; Jampílek, J.; Van Alsenoy, C.; War, J.A.; Al-Saadi, A.A. Vibrational spectroscopic and molecular docking study of (2E)-N-(4-Chloro-2-oxo-1,2-dihydroquinolin-3-yl)-3-phenylprop-2-enamide. Spectrochim. Acta A 2015, 151, 335-349.
  • Ulahannan, R.T.; Panicker, Y.C.; Varghese, H.T.; Musioł, R.; Jampílek, J.; Van Alsenoy, C.; War, J.A.; Srivastava, S.K. Molecular structure, FT-IR, FT-Raman, NBO, HOMO and LUMO, MEP, NLO and molecular docking study of 2-[(E)-2-(2-bromophenyl)ethenyl]quinoline-6-carboxylic acid. Spectrochim. Acta A 2015, 151, 184-197.
  • Ulahannan, R.T.; Panicker, Y.C.; Varghese, H.T.; Musioł, R.; Jampílek, J.; Van Alsenoy, C.; War, J.A.; Manojkumar, T.K. Vibrational Spectroscopic Studies and Molecular Docking Study of 2-[(E)-2-phenylethenyl]quinoline-5-carboxylic Acid. Spectrochim. Acta A 2015, 150, 190-199.
  • Kos, J.; Zadražilová, I.; Nevin, E.; Šoral, M.; Goněc, T.; Kollár, P.; Oravec, M.; Coffey, A.; O´Mahony, J.; Liptaj, T.; Kráľová, K.; Jampílek, J. Ring-substituted 8-Hydroxyquinoline-2-carboxanilides as Potential Antimycobacterial Agents. Bioorg. Med. Chem. 2015, 23 (15), 4188-4196.
  • Zadražilová, I.; Pospíšilová, Š.; Masaříková, M.; Imramovský, A.; Monreal-Férriz, J.; Vinšová, J.; Čížek, A.; Jampílek, J. Salicylanilide Carbamates: Promising Antibacterial Agents with High In Vitro Activity against Methicillin-resistant Staphylococcus aureus (MRSA). Eur. J. Pharm. Sci. 2015, 77, 197-207.
  • Goněc, T.; Zadražilová, I.; Nevin, E.; Kauerová, T.; Peško, M.; Kos, J.; Oravec, M.; Kollár, P.; Coffey, A.; O´Mahony, J.; Čížek, A.; Kráľová, K.; Jampílek, J. Synthesis and Biological Evaluation of N-Alkoxyphenyl-3-hydroxynaphthalene-2-carboxanilides. Molecules 2015, 20 (6), 9767-9787.
  • Vaculíková, E.; Plachá, D.; Jampílek, J. Toxicology of Drug Nanocarriers. Chem. Listy 2015, 109 (5), 346-352.
  • Kráľová, K.; Jampílek, J. Impact of Environmental Contaminants on Breast Cancer. Ecol. Chem. Eng. S. 2015, 22 (1), 9-44.
  • Jampílek, J.; Záruba, K.; Oravec, M.; Kuneš, M.; Babula, P.; Ulbrich, P.; Brezaniová, I.; Opatřilová, R.; Tříska, J.; Suchý, P. Preparation of Silica Nanoparticles Loaded with Nootropics and Their In Vivo Permeation through Blood–Brain Barrier. BioMed Res. Int. 2015, 2015, Article ID 812673 (9 pages).
  • Kos, J.; Nevin, E.; Šoral, M.; Kushkevych, I.; Goněc, T.; Bobál, P.; Kollár, P.; Coffey, A.; O´Mahony, J.; Liptaj, T.; Kráľová, K.; Jampílek, J. Synthesis and Antimycobacterial Properties of Ring-Substituted 6-Hydroxynaphthalene-2-Carboxanilides. Bioorg. Med. Chem. 2015, 23 (9), 2035-2043.
  • Kráľová, K.; Peřina, M.; Waisser, K.; Jampílek, J. Structure-Activity Relationships of N-benzylsalicylamides for Inhibition of Photosynthetic Electron Transport. Med. Chem. 2015, 11 (2), 156-164.
  • Zadražilová, I.; Pospíšilová, Š.; Pauk, K.; Imramovský, A.; Vinšová, J.; Čížek, A.; Jampílek, J. In Vitro Bactericidal Activity of 4- and 5-Chloro-2-hydroxy-N-[1-oxo-1-(phenylamino)alkan-2-yl]benzamides against MRSA. BioMed Res. Int. 2015, 2015, Article ID 349534 (8 pages).

2014

  • Jampílek, J. Recent      Advances in Design of Potential Quinoxaline Anti-Infectives. Curr. Med.      Chem. 2014, 21 (38), 4347-4373.
  • Vaculíková, E.; Plachá, D.; Pisárčik, M.; Peikertová, P.; Dědková,      K.; Devínský, F.; Jampílek, J. Preparation of Risedronate Nanoparticles by      Solvent Evaporation Technique. Molecules      2014, 19 (11), 17848-17861.
  • Krompiec, S.; Malarz, J.; Pietraszuk, C.; Powała, B.; Rogalski, S.; Małecki, J.G.; Penkala, M.; Filapek, M.; Musioł, R.; Jampílek, J.; Vejsová, M.; Polański, J.; Paluch, M.; Pawlus, S.; Danikiewicz, W.; Kania, M.; Marcol, B. New Strategy for the Synthesis of 3,4,5-Trisubstituted Isoxazolines from Allyl Compounds. Curr.      Org. Chem. 2014, 18 (17), 2280-2296.
  • Goněc, T.; Kos, J.; Nevin, E.; Govender, R.; Peško, M.; Tengler,      J.; Kushkevych, I.; Šťastná, V.; Oravec, M.; Kollár, P.; O´Mahony, J.;      Kráľová, K.; Coffey, A.; Jampílek, J. Preparation and Biological      Properties of Ring-Substituted Naphthalene-1-Carboxanilides. Molecules 2014, 19 (7),      10386-10409.
  • Imramovský, A.; Peško, M.; Jampílek, J.; Kráľová, K. Synthesis and Photosynthetic      Electron Transport Inhibition of 2-Substituted 6-Fluorobenzothiazoles. Monatsh. Chem. 2014, 145 (11),      1817-1824.
  • Bojňanská, E.; Kalina, M.; Pařízek, L.; Bartoníčková, E.; Opravil,      T.; Veselý, M.; Pekař, M.; Jampílek,      J. Determination of Critical Parameters of Drug Substance Influencing      Dissolution – A Case Study. BioMed      Res. Int. 2014, 2014, Article ID 929248 (9 pages).
  • Vaculíková, E.; Plachá, D.; Čech-Barabaszová, K.; Jampílek, J.      Cimetidine Nanoparticles Study. Adv.      Sci. Eng. Med. 2014, 6 (4), 477-481.
  • Vaverková, V.; Vrána, O.; Adam, V.; Pekárek, T.; Jampílek, J.;      Babula, P. The study of Naphthoquinones and its Complexes with DNA by      using Raman Spectroscopy and Surface Enhanced Raman Spectroscopy – New      Insight into Interactions of DNA with Plant Secondary Metabolites. BioMed Res. Int. 2014, 2014, Article ID 461393 (12 pages).
  • Ulahannan, R.T.; Panicker, Y.C.; Varghese, H.T.; van Alsenoy, C.;      Musioł, R.; Jampílek, J.; Anto, P.L. Vibrational Spectroscopic, 1H      NMR and Quantum Chemical Computational Study of      4-Hydroxy-2-oxo-1,2-dihydroquinoline-8-carboxylic Acid. Spectrochim. Acta A 2014, 121, 445-456.
  • Ulahannan, R.T.; Panicker, Y.C.; Varghese, H.T.; van Alsenoy, C.;      Musioł, R.; Jampílek, J.; Anto, P.L. Spectroscopic (FT-IR, FT-Raman)      Investigations and Quantum Chemical Calculations of      4-Hydroxy-2-oxo-1,2-dihydroquinoline-7-carboxylic acid. Spectrochim. Acta A 2014, 121, 404-414.
  • Černíková, A.; Jampílek, J. Structure Modification of Drugs      Influencing Their Bioavailability and Therapeutic Effect. Chem. Listy      2014, 108 (1), 7-16.

2013

  • Pauk, K.; Zadražilová, I.; Imramovský, A.; Vinšová, J.; Pokorná,      M.; Masaříková, M.; Čížek, A.; Jampílek, J. New Derivatives of      Salicylamides: Preparation and Antimicrobial Activity against Various      Bacterial Species. Bioorg. Med. Chem. 2013, 21 (21), 6574-6581.
  • Goněc, T.; Kos, J.; Zadražilová, I.; Peško, M.; Keltošová, S.;      Tengler, J.; Bobál, P.; Kollár, P.; Čížek, A.; Kráľová, K.; Jampílek, J.      Antimycobacterial and Herbicidal Activity of Ring-Substituted      1-Hydroxynaphthalene-2-carboxanilides. Bioorg. Med. Chem. 2013, 21 (21), 6531-6541.
  • Opatřilová, R.; Černíková, A.; Coufalová, L.; Dohnal, J.; Jampílek,      J. In vitro permeation of micronized and nanonized alaptide from      semi-solid formulations. Sci. World      J. 2013, 2013, Article ID 787283 (8 pages).
  • Jampílek, J. Transdermal Application of Drugs and Techniques      Affecting Skin Barrier. J. Bioequiv.      Availab. 2013, 5 (6), 233-235.
  • Tengler, J.; Kapustíková, I.; Peško, M.; Govender, R.; Keltošová,      S.; Mokrý, P.; Kollár, P.; O´Mahony, J.; Coffey, A.; Kráľová, K.; Jampílek,      J. Synthesis and Biological evaluation of      2-Hydroxy-3-[(2-aryloxyethyl)amino]propyl      4-[(alkoxycarbonyl)amino]benzoates. Sci.      World J. 2013, 2013, Article ID 274570 (13 pages).
  • Otevřel, J.; Bobál, P.; Zadražilová, I.; Govender, R.; Peško, M.;      Keltošová, S.; Kolečkářová, P.; Imramovský, A.; Coffey, A.; O´Mahony, J.;      Kollár, P.; Čížek, A.; Kráľová, K.; Jampílek, J. Antimycobacterial and      Photosynthetic Electron Transport Inhibiting Activity of Ring-Substituted      4-Arylamino-7-Chloroquinolinium Chlorides. Molecules 2013, 18 (9), 10648-10670.
  • Tengler, J.; Kapustíková, I.; Stropnický, O.; Mokrý, P.; Oravec,      M.; Csöllei, J.; Jampílek, J. Synthesis of New      (Arylcarbonyloxy)aminopropanol Derivatives and the Determination of Their      Physico-Chemical Properties. Cent.      Eur. J. Chem. 2013, 11 (11), 1757-1767.
  • Čulen, M.; Řezáčová, A.; Jampílek, J.; Dohnal, J. Designing a      Dynamic Dissolution Method: A Review of Instrumental Options and      Corresponding Physiology of Stomach and Small Intestine. J. Pharm. Sci. 2013, 102 (9), 2995-3017.
  • Mrózek, L.; Coufalová, L.; Rárová, L.; Plaček, L.; Opatřilová, R.;      Dohnal, J.; Kráľová, K.; Paleta, O.; Král, V.; Drašar, P.; Jampílek, J.      New Polyfluorothiopropanoyloxy Derivatives of 5β-Cholan-24-oic Acid      Designed as Drug Absorption Modifiers. Steroids      2013, 78 (9), 832-844.
  • Goněc, T.; Kos, J.; Zadražilová, I.; Peško, M.; Govender, R.;      Keltošová, S.; Kollár, P.; Imramovský, A.; O´Mahony, J.; Coffey, A.;      Čížek, A.; Kráľová, K.; Jampílek, J. Antibacterial and Herbicidal Activity of Ring-Substituted      2-Hydroxynaphthalene-1-carboxanilides. Molecules 2013, 18 (8), 9397-9419.
  • Kos, J.; Zadražilová, I.; Peško, M.; Keltošová, S.; Tengler, J.;      Goněc, T.; Bobál, P.; Kauerová, T.; Oravec, M.; Kollár, P.; Čížek, A.;      Kráľová, K.; Jampílek, J. Antibacterial      and Herbicidal Activity of Ring-Substituted      3-Hydroxynaphthalene-2-carboxanilides. Molecules 2013, 18 (7), 7977-7997.
  • Coufalová, L.; Mrózek, L.; Rárová, L.; Plaček, L.; Opatřilová, R.;      Dohnal, J.; Kráľová, K.; Paleta, O.; Král, V.; Drašar, P.; Jampílek, J.      New Propanoyloxy Derivatives of 5β-Cholan-24-oic Acid as Drug Absorption      Modifiers. Steroids 2013, 78 (5), 435-453.
  • Imramovský, A.; Pejchal, V.; Štěpánková, Š.; Vorčáková, K.;      Jampílek, J.; Vančo, J.; Šimůnek, P.; Královec, K.; Brůčková, L.;      Mandíková, J.; Trejtnar, F. Synthesis and In Vitro Evaluation of New      Derivatives of 2-Substituted-6-Fluorobenzo[d]thiazoles as Cholinesterase      Inhibitors. Bioorg. Med. Chem. 2013,      21 (7), 1735-1748.

2012

  • Fajkusová, D.; Peško, M.; Keltošová, S.; Guo, J.; Oktábec, Z.;      Vejsová, M.; Kollár, P.; Coffey, A.; Csöllei, J.; Kráľová, K.; Jampílek,      J. Anti-Infective and Herbicidal Activity of N-Substituted 2-Aminobenzothiazoles. Bioorg. Med. Chem.      2012, 20 (24), 7059-7068.
  • Cieslik, W.; Musioł, R.; Nycz, J.; Jampílek, J.; Vejsová, M.;      Wolff, M.; Machura, B.; Polański, J.      Contribution to Investigation of Antimicrobial Activity of      Styrylquinolines. Bioorg. Med. Chem. 2012, 20 (24), 6960-6968.
  • Vaculíková, E.; Grünwaldová, V.; Král, V.; Dohnal, J.; Jampílek, J.      Preparation of Candesartan and Atorvastatin Nanoparticles by Solvent      Evaporation. Molecules 2012, 17 (11), 13221-13234.
  • Vaculíková, E.; Grünwaldová, V.; Král, V.; Dohnal, J.; Jampílek, J.      Primary Investigation of the Preparation of Nanoparticles by      Precipitation. Molecules 2012, 17 (9), 11067-11078.
  • Jampílek, J.; Brychtová, K. Azone Analogues: Classification,      Design, and Transdermal Penetration Principles. Med. Res. Rev. 2012, 32 (5), 907-947.
  • Imramovský, A.; Štěpánková, Š.; Vančo, J.; Pauk, K.; Monreal-Férriz, J.; Vinšová,      J.; Jampílek, J. Acetylcholinesterase-Inhibiting Activity of      Salicylanilide N-Alkylcarbamates      and Their Molecular Docking. Molecules      2012, 17 (9), 10142-10158.
  • Kráľová, K.;      Jampílek, J.; Ostrovský, I. Metabolomics – Useful Tool for Study of Plant      Responses to Abiotic Stresses. Ecol.      Chem. Eng. S. 2012, 19 (2), 133-161.
  • Zitko, J.; Jampílek, J.; Dobrovolný, L.; Svobodová, M.; Kuneš, J.;      Doležal M. Synthesis and antimycobacterial evaluation of N-substituted      3-aminopyrazine-2,5-dicarbonitriles. Bioorg.      Med. Chem. Lett. 2012, 22 (4), 1598-1601.
  • Bobál, P.; Šujan, J.; Otevřel, J.; Imramovský, A.; Padělková, Z.;      Jampílek, J. Microwave-Assisted Synthesis of New Substituted Anilides of      Quinaldic Acid. Molecules 2012, 17 (2), 1292-1306.
  • Goněc, T.; Bobál, P.; Šujan, J.; Peško, M.; Guo, J.; Kráľová, K.; Kos,      J.; Coffey, A.; Kollár, P.; Imramovský, A.; Plaček, L.; Jampílek, J.      Investigating the Spectrum of Biological Activity of Substituted      Quinoline-2-Carboxamides and Their Isosteres. Molecules 2012, 17 (1), 613-644.
  • Brychtová, K.; Dvořáková, L.; Opatřilová, R.; Raich, I.; Káčerová,      S.; Plaček, L.; Kalinowski, D.; Richardson, D.R.; Jampílek, J.      Investigation of Substituted 6-Aminohexanoates as Skin Penetration      Enhancers. Bioorg. Med. Chem. 2012,      20 (1), 86-95.

2011

  • Pejchal, V.; Štěpánková, Š.; Padělková, Z.; Imramovský, A.;      Jampílek, J. 1,3-Substituted Imidazolidine-2,4,5-triones: Synthesis and      Inhibition of Cholinergic Enzymes. Molecules      2011, 16 (9), 7565-7582.
  • Mrózek, L.; Dvořáková, L.; Mandelová, Z.; Rárová, L.; Řezáčová, A.;      Plaček, L.; Opatřilová, R.; Dohnal, J.; Paleta, O.; Král, V.; Drašar, P.;      Jampílek, J. Investigation of New Acyloxy Derivatives of Cholic Acid and      Their Esters as Drug Absorption Modifiers. Steroids 2011, 76 (10-11), 1082-1097.
  • Imramovský, A.; Peško, M.; Monreal-Férriz, J.; Kráľová, K.;      Vinšová, J.; Jampílek, J. Photosynthesis-Inhibiting Efficiency of      4-Chloro-2-(chlorophenylcarbamoyl)phenyl alkylcarbamates. Bioorg. Med. Chem. Lett. 2011, 21      (15), 4564-4567.
  • Opletalová, V.; Doležel, J.; Kráľová, K.; Peško, M.; Kuneš, J.;      Jampílek, J. Synthesis and Characterization of (Z)-5-Arylmethylidenerhodanines with Photosynthesis-Inhibiting      Properties. Molecules 2011, 16 (6), 5207-5227.
  • Kos, J.; Pěntáková, M.; Oktábec, Z.; Krejčík, L.; Mandelová, Z.;      Pekárek, T.; Dammer, O.; Tkadlecová, M.; Havlíček, J.; Král, V.; Dohnal,      J.; Jampílek, J. Crystallization Products of Risedronate with      Carbohydrates and Their Substituted Derivatives. Molecules 2011, 16 (5), 3740-3760.
  • Mandelová, Z.; Opatřilová, R.; Raich, I.; Havlíček, J.; Káčerová,      S.; Pekárek, T.; Tkadlecová, M.; Dohnal, J.; Csőllei, J.; Jampílek, J.      Synthesis, Physico-Chemical Properties and DFT Calculations of New      2-(4-Arylpiperazine-1-yl)-1-(3-ethylbenzofuran-2-yl)ethanols As Potential      Antihypertensive Agents. Curr. Org. Chem. 2011, 15 (7), 1081-1096.
  • Imramovský, A.; Peško, M.; Kráľová, K.; Vejsová, M.; Stolaříková,      J.; Vinšová, J.; Jampílek, J. Investigating Spectrum of Biological      Activity of 4- and 5-Chloro-2-hydroxy-N-[2-(arylamino)-1-alkyl-2-oxoethyl]benzamides.      Molecules 2011, 16 (3),      2414-2430.

2010

  • Oktábec, Z.; Kos, J.; Mandelová, Z.; Pekárek, T.; Řezáčová, A.;      Plaček, L.; Tkadlecová, M.; Havlíček, J.; Dohnal, J.; Jampílek, J.      Preparation and Properties of New Co-Crystals of Ibandronate with Gluco-      or Galactopyranoside Derivatives. Molecules      2010, 15 (12), 8973-8987.
  • Doležal, M.; Zitko, J.; Osička, Z.; Kuneš, J.; Vejsová, M.; Buchta,      V.; Dohnal, J.; Jampílek, J.; Kráľová,      K. Synthesis, Antimycobacterial, Antifungal and      Photosynthesis-inhibiting Activity of Chlorinated N-phenylpyrazine-2-carboxamides. Molecules 2010, 15      (12), 8567-8581.
  • Brychtová, K.; Opatřilová, R.; Raich, I.; Kalinowski, D.;      Dvořáková, L.; Plaček, L.; Csőllei, J.; Richardson, D.R.; Jampílek, J.      Investigating the Activity of 2-Substituted      Alkyl-6-(2,5-dioxopyrrolidin-1-yl)hexanoates as Skin Penetration      Enhancers. Bioorg. Med. Chem. 2010,      18 (24), 8556-8565.
  • Skórska-Stania, A.; Śliwa, M.; Musílek, K.; Kuča, K.; Jampílek, J.; Musioł, R.; Oleksyn, B.; Dohnal, J. Selected AChE Reactors in Different      Crystalline Environment: Salts and Enzyme. Struct. Chem. 2010,      21 (3), 495-501.
  • Mrozek-Wilczkiewicz, A.; Kalinowski, D.; Musioł, R.; Finster, J.; Szurko, A.; Serafin, K.; Knas,      M.; Kovacevic, Z.; Jampílek, J.; Ratuszna, A.; Rzeszowska-Wolny J.; Richardson, D.R.; Polański, J. Investigating      Anti-proliferative Activity of Styrylazanaphthalenes and      Azanaphthalenediones. Bioorg. Med. Chem. 2010, 18 (7), 2664-2671.
  • Brychtová, K.; Jampílek, J.; Opatřilová, R.; Raich, I.; Farsa, O.;      Csőllei, J. Synthesis,      Physico-chemical Properties and Penetration Activity of      Alkyl-6-(2,5-dioxopyrrolidin-1-yl)-2-(2-oxopyrrolidin-1-yl)hexanoates as      Potential Transdermal Penetration Enhancers. Bioorg. Med. Chem. 2010, 18 (1), 73-79.

2009

  • Doležel, J.; Hiršová, P.; Opletalová, V.; Dohnal, J.; Vejsová, M.;      Kuneš, J.; Jampílek, J. Rhodanineacetic Acid Derivatives as Potential      Drugs: Preparation, Hydrophobic Properties and Antifungal Activity of      (5-Arylalkylidene-4-oxo-2-thioxo-1,3-thiazolidin-3-yl)acetic acids. Molecules 2009, 14 (10), 4197-4212.
  • Opatřilová, R.; Jampílek, J.; Raich, I.; Káčerová, S.; Havlíček,      J.; Pekárek, T.; Dohnal, J.; Csőllei,      J. Synthesis, Characterization and Physico-chemical Properties of      New 2-(4-Arylpiperazine-1-yl)-1-(3-methylbenzofuran-2-yl)ethanoles as      Potential Antihypertensive Agents. Curr. Org. Chem. 2009,      13 (10), 965-975.
  • Imramovský, A.; Vinšová, J.; Monreal-Férriz, J.; Doležal, R.;      Jampílek, J.; Kaustová, J.; Kunc,      F. New Antituberculotics Originated from Salicylanilides with Promising In      Vitro Activity against Atypical Mycobacterial Strains. Bioorg. Med.      Chem. 2009, 17 (10), 3572-3579.
  • Imramovský, A.; Vinšová, J.; Monreal-Férriz, J.; Buchta, V.;      Jampílek, J. Salicylanilide Esters of N-protected      Amino Acids as Novel Antimicrobial Agents. Bioorg. Med. Chem. Lett. 2009, 19 (2), 348-351.

2008

  • Opletalová, V.; Kalinowski, D.; Vejsová, M.; Kuneš, J.; Pour, M.; Jampílek, J.; Buchta, V.; Richardson, D.R. Identification and Characterization of      Thiosemicarbazones with Anti-Fungal and Anti-Tumor Effects: Cellular      Iron-Chelation Mediating Cytotoxic Activity. Chem. Res. Toxicol. 2008, 21 (9), 1878-1889.
  • Doležal, M.; Čmedlová, P.; Palek, L.; Vinšová, J.; Kuneš, J.;      Buchta, V.; Jampílek, J.; Kráľová,      K. Synthesis and      Antimycobacterial Evaluation of Substituted Pyrazinecarboxamides. Eur. J. Med. Chem. 2008, 43 (5), 1105-1113.
  • Jampílek, J.; Rečková, Z.; Imramovský, A.; Raich, I.; Vinšová, J.;      Dohnal, J. Study of Stability of New Mutual Prodrugs with      Antimycobacterial Activity. Curr. Org. Chem. 2008, 12 (8),      667-674.
  • Musioł, R.; Tabak, D.; Niedbala, H.; Podeszwa, B.; Jampílek, J.;      Kráľová, K.; Dohnal, J.; Finster, J.; Mencel, A.; Polański, J. Investigating Biological      Activity Spectrum for Novel Quinoline Analogues 2:      Hydroxyquinolinecarboxamides with Photosynthesis Inhibiting      Activity. Bioorg. Med. Chem. 2008,      16 (8), 4490-4499.
  • Palek, L.; Dvořák, J.; Svobodová, M.; Buchta, V.; Jampílek, J.;      Doležal, M. Synthesis, Antimycobacterial and Antifungal Evaluation of      3-Arylaminopyrazine-2,5-dicarbonitriles. Arch. Pharm. 2008, 341      (1), 61-65.
  • Vinšová, J.; Imramovský, A.; Jampílek, J.; Monreal-Férriz, J.;      Doležal, M. Recent Advances on Isoniazide      Derivatives. Anti-Infective Agents Med. Chem. 2008, 7 (1), 12-31.

2007

  • Podeszwa, B.; Niedbala, H.; Polański, J.; Musioł, R.; Tabak, D.; Finster,      J.; Serafin, K.; Wietrzyk, J.; Boryczka, S.; Mól, W.; Jampílek, J.;      Dohnal, J.; Kalinowski, D.; Richardson, D.R. Investigating the      Antiproliferative Activity of Quinoline-5,8-dione Analogues on Tumour Cell      Lines. Bioorg. Med. Chem. Lett. 2007, 17      (22), 6138-6141.
  • Jampílek, J.; Doležal, M.; Buchta,      V. Antimicrobial Evaluation of Some Arylsulfanylpyrazinecarboxylic Acid      Derivatives. Med. Chem. 2007, 3      (3), 277-280.
  • Imramovský, A.; Polanc, S.; Vinšová, J.; Kočevar, M.; Jampílek, J.;      Kaustová, J. A New Modification of Antitubercular Active Molecules. Bioorg. Med. Chem. 2007, 15 (7), 2551-2559.
  • Musioł, R.; Jampílek, J.; Kráľová, K.; Richardson, D.R.; Kalinowski, D.; Podeszwa, B.; Finster, J.; Niedbala, H.; Pałka,      A.; Polański, J. Investigating Biological Activity Spectrum for Novel Quinoline Analogues. Bioorg. Med. Chem. 2007, 15 (3), 1280-1288.

2006

  • Vinšová, J.; Čermáková, K.; Tomečková, A.; Čečková, M.; Jampílek,      J.; Čermák, P.; Kuneš, J.; Doležal, M.; Štaud, F. Synthesis and Antimicrobial Evaluation of New      2-Substituted 5,7-Di-tert-butylbenzoxazoles. Bioorg. Med. Chem. 2006, 14      (17), 5850-5865.
  • Musioł, R.; Jampílek, J.; Buchta, V.; Silva, L.; Niedbala, H.;      Podeszwa, B.; Pałka, A.; Majerz-Maniecka, K.; Oleksyn, B.; Polański, J. Antifungal Properties of New Series of Quinoline Derivatives. Bioorg. Med. Chem. 2006, 14 (10),      3592-3598.
  • Doležal, M.; Palek, L.; Vinšová, J.; Buchta, V.; Jampílek, J.;      Kráľová, K. Substituted      Pyrazinecarboxamides: Synthesis and Biological Evaluation. Molecules 2006, 11 (4), 242-256.
  • Jampílek, J.; Doležal, M.; Opletalová, V.; Hartl, J. 5-Lipoxygenase, Leukotrienes      Biosynthesis and Potential Antileukotrienic Agents. Curr. Med. Chem.      2006, 13 (2), 117-129.

2005–2003

  • Jampílek, J.; Doležal, M.; Kuneš, J.; Buchta, V.; Silva, L.;      Kráľová, K. Quinaldine Derivatives: Preparation and      Biological Activity. Med. Chem. 2005, 1 (6), 591-599.
  • Jampílek, J.; Doležal, M.; Kuneš, J.; Šatínský, D.; Raich,      I. Novel Regioselective Preparation of 5-Chloropyrazine-2-carbonitrile      from Pyrazine-2-carboxamide and Coupling Study of Substituted Phenylsulfanylpyrazine-2-carboxylic Acid      Derivatives. Curr. Org. Chem.      2005, 9 (1), 49-60.
  • Jampílek, J.; Doležal, M.; Kuneš, J.; Víchová, P.; Jun, D.; Raich, I.; O´Connor, R.; Clynes, M. Preparation of      2-(4-{[4-(Quinolin-2-ylmethoxy)phenyl]sulfanyl}phenyl)propionic Acid (VUFB      20615) and      2-Methyl-2-(4-{[4-(quinolin-2-ylmethoxy)phenyl]sulfanyl}phenyl)propionic      Acid (VUFB 20623) as Potential Antileukotrienic Agents. Curr.      Org. Chem. 2004, 8 (13), 1235-1243.
  • Jampílek, J.; Doležal, M.; Kuneš, J.; Víchová, P.; Jun, D.; Hanika, J.; O´Connor, R.; Clynes, M. Synthesis of (2E)-2-Methyl-3-(4-{[4-(quinolin-2-ylmethoxy)phenyl]sulfanyl}phenyl)prop-2-enoic      Acid (VUFB 20609) and 2-Methyl-3-(4-{[4-(quinolin-2-ylmethoxy)phenyl]sulfanyl}phenyl)propionic Acid (VUFB 20584) as Potential Antileukotrienic Agents. J. Pharm. Pharmacol. 2004, 56 (6), 783-794.
  • Doležal, M.; Jampílek, J.; Osička, Z.; Kuneš, J.; Buchta, V.;      Víchová, P. Substituted 5-Aroylpyrazine-2-carboxylic Acid Derivatives:      Synthesis and Biological Activity. Farmaco 2003, 58 (11),      1105-1111.

 

Selected Patents:

  • Jampílek, J.; Opatřilová, R.; Dvořáková, L.; Brychtová, K.; Dohnal,      J. Utilization of Alaptide as Transdermal Penetration Modifier in      Pharmaceutical Compositions for Human and Veterinary Applications      Containing Non-steroidal Anti-Inflammatory and/or Antipyretic-Analgesic      Drugs. CZ 304915 B6, December      10, 2014.
  • Jampílek, J.; Opatřilová, R.; Řezáčová, A.; Oktábec, Z.; Dohnal, J.      Alaptide: Methods of Effecting its Solubility,      Membrane Permeation and Pharmaceutical Compositions for Human and/or      Veterinary Applications. WO/2014/019556 A1, February      06, 2014.
  • Jampílek, J.; Opatřilová, R.; Coufalová, L.; Černíková, A.; Dohnal,      J. Utilization of Alaptide as Transdermal      Penetration Modifier in Pharmaceutical Compositions for Human and      Veterinary Applications Containing Anti-Inflammatory Drugs and/or      Antimicrobial Chemotherapeutics. WO/2013/020527      A1, February 14, 2013.
  • Král, V.; Oktábec, Z.; Jampílek, J.; Pekárek, T.; Proksa, B.;      Dohnal, J.; Malovíková, A.; Ebringerová, A.; Řezáčová, A. Increase of API water-solubility and colon targeted drug      delivery systems. CZ 302789 B6,      September 29, 2011.
  • Mudra, P.; Pokorný, V.; Pešek, V.; Poncar, P.; Bárta, J.; Řezáčová,      A.; Jampílek, J.; Dohnal, J.; Král,      V. Digestive Tract Simulator. WO/2011/069472      A1, June 16, 2011.
  • Král, V.; Oktábec, Z.; Jampílek, J.; Pekárek, T.; Proksa, B.;      Dohnal, J.; Malovíková, A.; Ebringerová, A.; Řezáčová, A.. Pectin      Complexes of Sartans and Pharmaceutical Compositions Based Thereon. WO/2011/063775 A2, June 03, 2011.
  • Král, V.; Oktábec, Z.; Jampílek, J.; Pekárek, T.; Proksa, B.;      Dohnal, J.; Malovíková, A.; Ebringerová, A.; Řezáčová, A. Pectin complexes of steroids and pharmaceutical compositions based thereon. WO/2011/063774      A2, June 03, 2011.
  • Mudra, P.; Pokorný, V.; Pešek, V.; Poncar, P.; Bárta, J.; Řezáčová,      A.; Jampílek, J.; Dohnal, J.; Král,      V. Digestive Tract Simulator. CZ      302422 B6, March 30, 2011.
  • Král, V.; Brusová, H.; Jampílek, J.; Havlíček, J.; Pekárek, T.;      Tkadlecová, M. Imatinib Mesylate      Polymorphs Generated by Crystallization in Aqueous Inorganic Salt      Solutions. WO/2011/023146      A1, March, 03, 2011.
  • Král, V.; Jampílek, J.; Havlíček, J.; Brusová, H.; Pekárek, T. Dosage Forms of Tyrosine      Kinase Inhibitors. WO/2010/081443      A2, July, 22, 2010.
  • Svoboda, M.; Jampílek, J.; Kačírková, M.; Tomášek, V.; Lehocký, M.;      Hejtmánková, L.; Vosátka, V. Crystalline Tolterodine Tartarate and a      Pharmaceutical Composition Containing the Same. WO/2008/017278 A3,      August 28, 2008.
  • Musioł, R.; Jampílek, J.; Buchta, V.; Kráľová, K.; Finster, J.;      Podeszwa, B.; Tabak, D.; Polański, J. Quinazoline      derivatives as fungicides and herbicides and their application. PL      379252 A1, October 01, 2007.
  • Svoboda, M.; Jampílek, J.; Kačírková, M.; Tomášek, V.; Lehocký, M. Pharmaceutical composition      containing tolterodine. CZ 298448 B6,      August 24, 2007.
  • Svoboda, M.; Jampílek, J.; Šebek,      P. Pharmaceutical composition of clopidogrel hydrogenbromide. CZ 298349 B6, July 25, 2007.
  • Musioł, R.; Jampílek, J.; Buchta, V.; Niedbala, H.; Pałka, A.;      Podeszwa, B.; Polański, J. Quinoline derivatives acting activity as      fungicides and their application. PL 375805 A1, December 27,      2006.
  • Musioł, R.; Jampílek, J.; Kráľová, K.; Niedbala, H.; Pałka, A.;      Podeszwa, B.; Polański, J. Derivatives of quinoline featuring activity as      herbicides and algicides, their precursors, methods for their manufacture      and their applications. PL 375678 A1, December 27, 2006.

 

Books and book chapters:

  • Jampílek, Josef and KRÁĽOVÁ, Katarína. Nanopesticides: Preparation,      targeting and controlled release. In: Nanotechnology in Food Industry,      Vol. 10 – New Pesticides and Soil Sensors. Alexandru M. Grumezescu (Ed.).      Elsevier, UK, 2016, Chapter 4. [ISBN 978-012-804-299-1]
  • Jampílek, Josef and Dohnal, Jiří. Alaptide as Transdermal Permeation Modifier. In:      Percutaneous Penetration Enhancers, Chemical Methods in Penetration      Enhancement: Modification of the Stratum Corneum. Nina Dragicevic-Curic,      Howard I. Maibach (Eds.). Springer-Verlag Berlin Heidelberg, Germany, 2015, Chapter 8, p. 115-132. [ISBN 978-3-662-47038-1]
  • Jampílek, Josef. Azone and Its Analogues. In: Percutaneous Penetration      Enhancers, Chemical Methods in Penetration Enhancement: Modification of      the Stratum Corneum. Nina Dragicevic-Curic, Howard I. Maibach (Eds.). Springer-Verlag      Berlin Heidelberg, Germany, 2015,      Chapter 6, p. 69-106. [ISBN 978-3-662-47038-1]
  • Jampílek, J.; Dohnal,      J. Investigation of Carbohydrates and Their Derivatives as Crystallization      Modifiers. In: Carbohydrates –      Comprehensive Studies on Glycobiology and Glycotechnology. Chuan-Fa      Chang (Ed.). InTech, Rijeka, Croatia, 2012, Chapter 5, pp. 81-116. [ISBN      979-953-307-908-9]
  • Doležal, M.; Zitko, J.; Jampílek, J. Pyrazinecarboxylic Acid      Derivatives with Antimycobacterial Activity. In: Understanding Tuberculosis – New Approaches to Fighting Against      Drug Resistance. Pere-Joan Cardona (Ed.). InTech, Rijeka, Croatia,      2012, Chapter 10, pp. 233-262. [ISBN 978-953-307-948-6]
  • Dohnal, J.; Jampílek, J.; Řezáčová, A.; Plaček, L.; Grünwaldová,      V.; Brusová, H.; Havlíček, J.; Pekárek, T.; Grafnetterová, T.; Opatřilová,      R.; Krumbholcová, L.; Setnička, V.; Urbanová M.; Král, V. Modern Approaches to Pharmaceutical      Analysis (in Czech). Jiří      Dohnal, Josef Jampílek, Vladimír Král, Anna Řezáčová (Eds.). Faculty of      Pharmacy, University of Veterinary and Pharmaceutical Sciences      Brno, Czech Republic, 2010, 500 pp. [ISBN 978-80-7305-085-6]